Ascletis Pharma Liabilities 2024

Ascletis Pharma Aktienanalyse

What does Ascletis Pharma do?

Ascletis Pharma Inc is a bio-pharmaceutical company that was founded in Hong Kong in 2009. The focus of the company is the development and marketing of drugs for the treatment of infectious diseases and cancer. The business model of Ascletis Pharma Inc is based on research and development, as well as sales and marketing activities. The company collaborates closely with academic institutions and clinical researchers to discover and develop new drugs. In recent years, Ascletis has received various awards and recognitions for its products. The company's portfolio includes various areas, such as the treatment of viral infectious diseases like hepatitis B and C infections. They have also developed drugs for the treatment of solid tumors, such as gastric cancer and liver cancer. Alongside medical research, Ascletis also conducts various sales and marketing activities. The company works with partners to market its products worldwide. In summary, Ascletis Pharma Inc is an emerging bio-pharmaceutical company specializing in the development of drugs for the treatment of infectious diseases and cancer. The business model is based on research and development, as well as sales and marketing of products. The company has various divisions and offers a variety of products. Ascletis has experienced continuous growth in recent years and is considered one of the most innovative companies in the industry. Ascletis Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Ascletis Pharma's Liabilities

Ascletis Pharma's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ascletis Pharma's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Ascletis Pharma's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Ascletis Pharma's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Ascletis Pharma’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Ascletis Pharma Stock

What is the level of liabilities of Ascletis Pharma this year?

Ascletis Pharma has a debt balance of 148.94 M CNY this year.

What were the liabilities of Ascletis Pharma compared to the previous year?

The liabilities of Ascletis Pharma have increased by 27.13% increased compared to the previous year.

What are the consequences of high debt for investors of Ascletis Pharma?

High liabilities can pose a risk for investors of Ascletis Pharma, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Ascletis Pharma?

Low liabilities mean that Ascletis Pharma has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Ascletis Pharma affect the company?

An increase in liabilities of Ascletis Pharma can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Ascletis Pharma affect the company?

A decrease in the liabilities of Ascletis Pharma can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Ascletis Pharma?

Some factors that can influence the liabilities of Ascletis Pharma include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Ascletis Pharma so important for investors?

The liabilities of Ascletis Pharma are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Ascletis Pharma take to modify the liabilities?

To change its liabilities, Ascletis Pharma can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Ascletis Pharma pay?

Over the past 12 months, Ascletis Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ascletis Pharma is expected to pay a dividend of 0 CNY.

What is the dividend yield of Ascletis Pharma?

The current dividend yield of Ascletis Pharma is .

When does Ascletis Pharma pay dividends?

Ascletis Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ascletis Pharma?

Ascletis Pharma paid dividends every year for the past 0 years.

What is the dividend of Ascletis Pharma?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ascletis Pharma located?

Ascletis Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ascletis Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ascletis Pharma from 6/29/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 6/29/2024.

When did Ascletis Pharma pay the last dividend?

The last dividend was paid out on 6/29/2024.

What was the dividend of Ascletis Pharma in the year 2023?

In the year 2023, Ascletis Pharma distributed 0 CNY as dividends.

In which currency does Ascletis Pharma pay out the dividend?

The dividends of Ascletis Pharma are distributed in CNY.